The primary goal of therapeutic hypothermia is to protect the brain and minimize the extent of neurological damage. Research has shown that cooling therapy can significantly improve outcomes for newborns with HIE. By reducing the metabolic rate of brain cells, therapeutic hypothermia slows down the processes that can lead to cell death and brain injury.
